Renal Biopsy in Type 2 Diabetic Patients.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4470212)

Published in J Clin Med on May 18, 2015

Authors

Eugenia Espinel1, Irene Agraz2, Meritxell Ibernon3, Natalia Ramos4, Joan Fort5, Daniel Serón6

Author Affiliations

1: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. eespinel@vhebron.net.
2: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. iagraz@vhebron.net.
3: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. mibernon@vhebron.net.
4: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. nramos@vhebron.net.
5: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. jfort@vhebron.net.
6: Nephrology Department, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. dseron@vhebron.net.

Associated clinical trials:

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination | NCT04143412

Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic Patients | NCT05021705

Articles cited by this

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45

The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38

Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA (2003) 5.33

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care (1998) 4.49

Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis (2004) 4.20

Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 2.84

Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia (1996) 1.98

Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85

Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79

Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant (2014) 1.56

Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract (2012) 1.32

Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care (2002) 1.27

The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol (2013) 1.26

Immunopathology of renal extracellular membranes in diabetes mellitus. Specificity of tubular basement-membrane immunofluorescence. Diabetes (1976) 1.12

Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes (2014) 1.06

Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol (2010) 1.01

Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J Diabetes (2013) 0.98

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. J Am Soc Nephrol (2014) 0.97

Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology (Carlton) (2012) 0.96

Diabetic nephropathy: landmark clinical trials and tribulations. Nephrol Dial Transplant (2015) 0.87

Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant (2013) 0.87

Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. Diabetes Metab Res Rev (2015) 0.86

Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol (2013) 0.84

The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD. Blood Purif (2006) 0.84

Epidemiology of diabetic nephropathy in Spain. Kidney Int Suppl (2005) 0.79

Clinical manifestations and natural history of diabetic kidney disease. Med Clin North Am (2013) 0.79

[Control of type 2 diabetes mellitus in Spain today: identification of the main obstacles in daily clinical practice]. Med Clin (Barc) (2013) 0.77